Literature DB >> 21099232

The eye as a common site for the early clinical manifestation of sarcoidosis.

Arnd Heiligenhaus1, Dirk Wefelmeyer, Elfa Wefelmeyer, Martin Rösel, Mathias Schrenk.   

Abstract

AIMS: Our purpose was to detect the rate of initial manifestation of sarcoidosis in the eye.
MATERIAL AND METHODS: We conducted a retrospective chart review in a sarcoidosis clinic in Germany. Ophthalmological data were obtained by using a standardized protocol, including the medical history, any comorbidity, onset and type of ocular manifestation that was evaluated by slit lamp, tonometry and fundoscopy.
RESULTS: In the cohort of 1,800 patients (mean age 38.1 ± 11.8 years), diagnosis of sarcoidosis was established most commonly by bilateral hilar lymphadenopathy (96.2%), histopathology (46.9%) or other organ manifestations. The initial clinical presentation of sarcoidosis (mean age 34.1 ± 10.8 years) had often been eye manifestation (21.2%). Within this group, anterior uveitis was most common (76.4%), followed by intermediate (17.3%) and posterior uveitis (4.7%).
CONCLUSIONS: The eye is commonly the first site for manifestation of sarcoidosis. Ophthalmologists have a critical role in establishing the diagnosis of sarcoidosis.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 21099232     DOI: 10.1159/000321947

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  18 in total

Review 1.  Ocular Sarcoidosis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Clin Chest Med       Date:  2015-12       Impact factor: 2.878

2.  Sarcoidosis in the national veteran population: association of ocular inflammation and mortality.

Authors:  Andrea D Birnbaum; Dustin D French; Mehdi Mirsaeidi; Sarah Wehrli
Journal:  Ophthalmology       Date:  2015-02-14       Impact factor: 12.079

Review 3.  Cutting-edge issues in autoimmune uveitis.

Authors:  Roger A Levy; Francisco Assis de Andrade; Ivan Foeldvari
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 4.  Sarcoidosis of the head and neck.

Authors:  Arvind K Badhey; Sameep Kadakia; Ricardo L Carrau; Codrin Iacob; Azita Khorsandi
Journal:  Head Neck Pathol       Date:  2014-09-03

Review 5.  [Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].

Authors:  I Kötter; N Stübiger; C Deuter
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

6.  Retinal Pigment Epithelium Tear after Immunosuppressive Treatment for Sarcoidosis-related Choroidal Granuloma.

Authors:  Jared E Knickelbein; Maggie Wei; Robert B Nussenblatt; H Nida Sen
Journal:  Ocul Immunol Inflamm       Date:  2016-07-05       Impact factor: 3.070

7.  Clinical Characteristics of Ocular Sarcoidosis: A Population-Based Study 1976-2013.

Authors:  Patompong Ungprasert; Andrea A Tooley; Cynthia S Crowson; Eric L Matteson; Wendy M Smith
Journal:  Ocul Immunol Inflamm       Date:  2017-10-12       Impact factor: 3.070

Review 8.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

Review 9.  Gender and ocular manifestations of connective tissue diseases and systemic vasculitides.

Authors:  Maria M Choudhary; Rula A Hajj-Ali; Careen Y Lowder
Journal:  J Ophthalmol       Date:  2014-03-17       Impact factor: 1.909

10.  Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.

Authors:  Enken Gundlach; Michael Marcus Hoffmann; Antje Prasse; Sonja Heinzelmann; Thomas Ness
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.